ESH How to Diagnose and Treat meetings are disease-specific meetings that address up to date diagnostic and clinical management which is greatly facilitated by presentation and discussion of real clinical cases. Intensive interaction between the speakers and participants will be helpful in spreading knowledge. Novel and still evolving insights into the biology and diagnosis of acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemias (ALL), has resulted in new drug approvals and new therapeutic options to treat newly-diagnosed as well as relapsed/refractory disease. Recently updates on prognostication and classification of acute leukaemias have been published which will be discussed in various sessions. Chairs: Hervé Dombret, Christoph Röllig, Wendy Stock

The programme of this “How to Diagnose and Treat: Acute Leukaemias” includes genomic analysis and cutting-edge technics in routine diagnosis, targeted therapies and standard of care treatments allogeneic haematopoietic stem cell transplantation (HSCT) transplantation and innovative immunotherapies, as well as diagnosis and management of rare acute leukaemia subtypes. Clonal hematopoiesis will be covered in detail. Novel trial designs instrumental for smarter drug development is discussed in a separate session.

 

This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.

 

The meeting will be of interest to:

• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)

• Junior scientists and clinicians (MD, PhD)

• PhD candidates and clinical residents still in-training

 

Learning Objectives:

Knowledge of Classification of ALL and AML

Insight in prognosis of ALL and AML

Application of MRD

Knowledge of established and novel treatment options in ALL and AML

Indications of alloSCT

Management of challenging subgroups of AML and ALL

Controversies on clinical trials and treatment options

 

Scientific Topics:

–  Dilemmas in acute leukaemias

– Novel treatments

– Diagnosis and treatment of rare diseases and rare subsets

– MRD a proper surrogate endpoint in AML

– Optimizing outcomes in acute leukaemias using supportive strategies

– Immune targeting strategies in ALL

– Real-world AML therapy

– Blina-TKI is enough to cure Ph-positive ALL

– HSC transplantation

– Leukaemia treatment challenges

 

The programme will include:

- Plenary Sessions

- Interactive Case Presentations

- Roundtables

- Panel Discussions

- Debates

- Poster Walks

- Meet the Expert Sessions

- Voting technology

- Ample time for in-depth discussion

Register here

Direct email queries to: [email protected]

External Events

Nov 26
24
25
26
Jan 27
18
19
28
Feb 27
1
24
25
26
November 24th 2026
Current Thinking in Haematological Malignancies...
The programme for this meeting has been designed to combine high calibre lectures and interactive discussions to prov...
Details
November 25th 2026
RCPath & SHOT Advances in Transfusion Symposium...
This popular biennial symposium brings together expert speakers in transfusion medicine and science. It is suitable f...
Details
November 26th 2026
Glasgow Surgical Forum 2026
Advances in Surgical Oncology: Evidence, Practice and Outcomes'. An essential update for the general and specialist s...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
November 26th 2026
UK Blood Cancer ECR Network Launch (1)
We are excited to launch the UKBCRN ECR network, which aims to support early-career researchers with an interest in h...
Details
January 18th 2027
Multiple Myeloma Preceptorship 2027
Join us for our face-to-face preceptorship programme. You will receive the latest updates regarding Multiple Myeloma...
Details
January 19th 2027
Post ASH Significant Highlights (6)
An annual January event , where highlights will be presented from the ASH meeting. The aim of this 2 day event is to...
Details
January 28th 2027
Innovations in Transplant and Cellular Therapy
The programme for the Innovations in Transplant and Cellular Therapy Day will focus on novel therapies, transplant co...
Details
February 1st 2027
CLL and Lymphomas in Practice Preceptorship 2027
Join us to explore the latest approaches to managing chronic lymphocytic leukaemia (CLL), follicular lymphoma, margin...
Details
February 24th 2027
UCLH: Challenges in MPN - Medical
Join us for a clinically focused and highly interactive study day dedicated to the management of complex MPN (myelopr...
Details
February 25th 2027
UCLH: Challenges in MPN - Nursing
This study day has been designed specifically for Clinical Nurse Specialists working with patients living with myelop...
Details
February 26th 2027
OB Shock: Hemorrhage, Hemodynamics & Hemostasis...
This multidisciplinary workshop advances clinical decision-making in complex obstetric hemorrhage through applied coa...
Details